TickerFacts.

Integra Lifesciences Holdings Corp (IART): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2013-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$98.97M
Year ended 2025-12-31
$95.00M
Trailing 12 months to 2026-06-30
-0.7%
3-year compound annual growth
+5.0%
5-year compound annual growth
+6.9%
10-year compound annual growth
$115.38M2008-12-31: $60.49M2009-12-31: $44.28M2010-12-31: $48.11M2011-12-31: $51.45M2012-12-31: $51.01M2013-12-31: $42.62M2014-12-31: $43.56M2015-12-31: $50.90M2016-12-31: $58.16M2017-12-31: $63.45M2018-12-31: $78.04M2019-12-31: $79.57M2020-12-31: $77.38M2021-12-31: $93.05M2022-12-31: $101.19M2023-12-31: $104.19M2024-12-31: $115.38M2025-12-31: $98.97M$98.97M
2008-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$98.97M-14.2%2026-02-26, From 2025-01-01
2024-12-31$115.38M+10.7%2026-02-26, From 2024-01-01
2023-12-31$104.19M+3.0%2026-02-26, From 2023-01-01
2022-12-31$101.19M+8.8%2025-02-25, From 2022-01-01
2021-12-31$93.05M+20.3%2024-02-28, From 2021-01-01
2020-12-31$77.38M-2.8%2023-02-22, From 2020-01-01
2019-12-31$79.57M+2.0%2022-02-24, From 2019-01-01
2018-12-31$78.04M+23.0%2021-02-23, From 2018-01-01
2017-12-31$63.45M+9.1%2020-02-21, From 2017-01-01
2016-12-31$58.16M+14.3%2019-02-26, From 2016-01-01
2015-12-31$50.90M+16.8%2018-03-01, From 2015-01-01
2014-12-31$43.56M+2.2%2017-02-23, From 2014-01-01
2013-12-31$42.62Mn/c2016-02-26, From 2013-01-01
2012-12-31$51.01M-0.9%2015-02-27, From 2012-01-01
2011-12-31$51.45M+6.9%2014-02-27, From 2011-01-01
2010-12-31$48.11M+8.7%2013-02-26, From 2010-01-01
2009-12-31$44.28M-26.8%2012-02-27, From 2009-01-01
2008-12-31$60.49Mn/a2011-02-24, From 2008-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Integra Lifesciences Holdings Corp (IART)2025-12-31$98.97M-14.2%
Merit Medical Systems Inc (MMSI)2025-12-31$97.35M+11.3%
Penumbra Inc (PEN)2025-12-31$89.77M-5.3%
Teleflex Inc (TFX)2025-12-31$144.78M+32.8%
Haemonetics Corp (HAE)2026-03-28$59.77M-4.7%
ICU Medical Inc (ICUI)2025-12-31$87.50M-1.3%
Embecta Corp. (EMBC)2025-09-30$37.30M-52.7%
Tandem Diabetes Care Inc (TNDM)2025-12-31$193.11M-2.9%
Insulet Corp (PODD)2025-12-31$301.10M+37.1%

Compare IART, MMSI, PEN, TFX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗